同源康医药-B盘中异动急速下跌5.20%报33.700港元

市场透视2025-03-11

2025年03月11日早盘09时33分，同源康医药-B（02410.hk）股票出现异动，股价快速下挫5.20%。截至发稿，该股报33.700港元/股，成交量3.25万股，换手率0.01%，振幅5.34%。资金方面，该股资金流入7.0875万港元，流出61.395万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-29.48倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518340927?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-11 09:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518340927","market":"hk","top_or_hot":-1,"title":"同源康医药-B盘中异动 急速下跌5.20%报33.700港元","media":"市场透视","content":"<div>\n<p>2025年03月11日早盘09时33分，同源康医药-B（02410.hk）股票出现异动，股价快速下挫5.20%。截至发稿，该股报33.700港元/股，成交量3.25万股，换手率0.01%，振幅5.34%。资金方面，该股资金流入7.0875万港元，流出61.395万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-29.48倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093302abf4841b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>同源康医药-B盘中异动 急速下跌5.20%报33.700港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n同源康医药-B盘中异动 急速下跌5.20%报33.700港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-11 09:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093302abf4841b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年03月11日早盘09时33分，同源康医药-B（02410.hk）股票出现异动，股价快速下挫5.20%。截至发稿，该股报33.700港元/股，成交量3.25万股，换手率0.01%，振幅5.34%。资金方面，该股资金流入7.0875万港元，流出61.395万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-29.48倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093302abf4841b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093302abf4841b&s=b","article_id":"2518340927","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311093302abf4841b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518340927","pubTimestamp":1741656782,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2025年03月11日早盘09时33分，同源康医药-B股票出现异动，股价快速下挫5.20%。截至发稿，该股报33.700港元/股，成交量3.25万股，换手率0.01%，振幅5.34%。资金方面，该股资金流入7.0875万港元，流出61.395万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.08%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09939":"开拓药业-B","BK1161":"生物科技","BK1574":"生物医药B类股","BK1515":"抗疫概念","02410":"同源康医药-B"},"translate_title":"Tongyuankang Pharmaceutical-B fell sharply by 5.20% to HK $33.700 during the session","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09939":1,"02410":1},"content_text":"2025年03月11日早盘09时33分，同源康医药-B（02410.hk）股票出现异动，股价快速下挫5.20%。截至发稿，该股报33.700港元/股，成交量3.25万股，换手率0.01%，振幅5.34%。资金方面，该股资金流入7.0875万港元，流出61.395万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.40亿港元，每股收益-0.75港元，毛利数据暂无，市盈率-29.48倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，荃信生物-B、百济神州、东曜药业-B涨幅较大，振幅较大的相关个股有方达控股、科伦博泰生物-B、欧康维视生物-B，振幅分别为10.58%、6.59%、6.53%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发,其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI,对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518340927","isCrawlerRequest":true}

同源康医药-B盘中异动 急速下跌5.20%报33.700港元

精彩评论

同源康医药-B盘中异动急速下跌5.20%报33.700港元